Phenotypes and distribution of mucosal memory B-cell populations in the SIV/SHIV rhesus macaque model

Published by Elsevier Inc.

Bibliographische Detailangaben
Veröffentlicht in:Clinical immunology (Orlando, Fla.). - 1999. - 153(2014), 2 vom: 01. Aug., Seite 264-76
1. Verfasser: Demberg, Thorsten (VerfasserIn)
Weitere Verfasser: Mohanram, Venkatramanan, Venzon, David, Robert-Guroff, Marjorie
Format: Online-Aufsatz
Sprache:English
Veröffentlicht: 2014
Zugriff auf das übergeordnete Werk:Clinical immunology (Orlando, Fla.)
Schlagworte:Journal Article Research Support, N.I.H., Intramural Homing markers Mucosal memory B cell phenotypes and distribution Plasmablasts/plasma cells SIV/SHIV rhesus macaque model Antigens, CD19 Antigens, CD20 Histocompatibility Antigens Class II Immunoglobulin A mehr... Interferon Regulatory Factors Ki-67 Antigen Receptors, Chemokine Syndecan-1 interferon regulatory factor-4
LEADER 01000naa a22002652 4500
001 NLM238118029
003 DE-627
005 20231224113108.0
007 cr uuu---uuuuu
008 231224s2014 xx |||||o 00| ||eng c
024 7 |a 10.1016/j.clim.2014.04.017  |2 doi 
028 5 2 |a pubmed24n0793.xml 
035 |a (DE-627)NLM238118029 
035 |a (NLM)24814239 
035 |a (PII)S1521-6616(14)00125-9 
040 |a DE-627  |b ger  |c DE-627  |e rakwb 
041 |a eng 
100 1 |a Demberg, Thorsten  |e verfasserin  |4 aut 
245 1 0 |a Phenotypes and distribution of mucosal memory B-cell populations in the SIV/SHIV rhesus macaque model 
264 1 |c 2014 
336 |a Text  |b txt  |2 rdacontent 
337 |a ƒaComputermedien  |b c  |2 rdamedia 
338 |a ƒa Online-Ressource  |b cr  |2 rdacarrier 
500 |a Date Completed 05.09.2014 
500 |a Date Revised 21.10.2021 
500 |a published: Print-Electronic 
500 |a Citation Status MEDLINE 
520 |a Published by Elsevier Inc. 
520 |a As vaccine-elicited antibodies have now been associated with HIV protective efficacy, a thorough understanding of mucosal and systemic B-cell development and maturation is needed. We phenotyped mucosal memory B-cells, investigated isotype expression and homing patterns, and defined plasmablasts and plasma cells at three mucosal sites (duodenum, jejunum and rectum) in rhesus macaques, the commonly used animal model for pre-clinical vaccine studies. Unlike humans, macaque mucosal memory B-cells lacked CD27 expression; only two sub-populations were present: naïve (CD21(+)CD27(-)) and tissue-like (CD21(-)CD27(-)) memory. Similar to humans, IgA was the dominant isotype expressed. The homing markers CXCR4, CCR6, CCR9 and α4β7 were differentially expressed between naïve and tissue-like memory B-cells. Mucosal plasmablasts were identified as CD19(+)CD20(+/-)HLA-DR(+)Ki-67(+)IRF4(+)CD138(+/-) and mucosal plasma cells as CD19(+)CD20(-)HLA-DR(-)Ki-67(-)IRF4(+)CD138(+). Both populations were CD39(+/-)CD27(-). Plasma cell phenotype was confirmed by spontaneous IgA secretion by ELISpot of positively-selected cells and J-chain expression by real-time PCR. Duodenal, jejunal and rectal samples were similar in B-cell memory phenotype, isotype expression, homing receptors and plasmablast/plasma cell distribution among the three tissues. Thus rectal biopsies adequately monitor B-cell dynamics in the gut mucosa, and provide a critical view of mucosal B-cell events associated with development of vaccine-elicited protective immune responses and SIV/SHIV pathogenesis and disease control 
650 4 |a Journal Article 
650 4 |a Research Support, N.I.H., Intramural 
650 4 |a Homing markers 
650 4 |a Mucosal memory B cell phenotypes and distribution 
650 4 |a Plasmablasts/plasma cells 
650 4 |a SIV/SHIV rhesus macaque model 
650 7 |a Antigens, CD19  |2 NLM 
650 7 |a Antigens, CD20  |2 NLM 
650 7 |a Histocompatibility Antigens Class II  |2 NLM 
650 7 |a Immunoglobulin A  |2 NLM 
650 7 |a Interferon Regulatory Factors  |2 NLM 
650 7 |a Ki-67 Antigen  |2 NLM 
650 7 |a Receptors, Chemokine  |2 NLM 
650 7 |a Syndecan-1  |2 NLM 
650 7 |a interferon regulatory factor-4  |2 NLM 
700 1 |a Mohanram, Venkatramanan  |e verfasserin  |4 aut 
700 1 |a Venzon, David  |e verfasserin  |4 aut 
700 1 |a Robert-Guroff, Marjorie  |e verfasserin  |4 aut 
773 0 8 |i Enthalten in  |t Clinical immunology (Orlando, Fla.)  |d 1999  |g 153(2014), 2 vom: 01. Aug., Seite 264-76  |w (DE-627)NLM098196855  |x 1521-7035  |7 nnns 
773 1 8 |g volume:153  |g year:2014  |g number:2  |g day:01  |g month:08  |g pages:264-76 
856 4 0 |u http://dx.doi.org/10.1016/j.clim.2014.04.017  |3 Volltext 
912 |a GBV_USEFLAG_A 
912 |a SYSFLAG_A 
912 |a GBV_NLM 
912 |a GBV_ILN_11 
912 |a GBV_ILN_24 
912 |a GBV_ILN_350 
951 |a AR 
952 |d 153  |j 2014  |e 2  |b 01  |c 08  |h 264-76